SCHEMBL974435

SCHEMBL974435

O=C(NO)c1cn(-c2ccccn2)nc1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.57
CA9 Q16790 2/20 0.57
KMT2A Q03164 5/20 0.54
AURKA O14965 4/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 5/20 0.50
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 4/20 0.50
LMNA P02545 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
KDM5B Q9UGL1 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CDK2 P24941 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16835734 0.86 ALDH1A1 (0.59) CA12CA9KMT2AAURKATP53
SCHEMBL976547 0.82 AURKA (0.74) CA12CA9KMT2AAURKATP53
SCHEMBL977581 0.74 MEN1 (0.69) CA12CA9KMT2AAURKATP53
SCHEMBL974862 0.72 CA12 (0.61) CA12CA9KMT2AAURKATP53
SCHEMBL3835980 0.71 ALKBH2 (0.52) KMT2AMAPTALDH1A1MEN1LMNA
SCHEMBL12282553 0.71 ALKBH2 (0.52) KMT2ATP53MAPTALDH1A1MEN1
SCHEMBL974635 0.70 KLKB1 (0.67) CA12CA9KMT2AALDH1A1MEN1
SCHEMBL23928515 0.70 AURKA (0.79) CA12CA9KMT2AAURKATP53
SCHEMBL11166052 0.70 KDM4E (0.72) KMT2AAURKAMAPTALDH1A1KDM4E
SCHEMBL6256569 0.70 AURKA (0.72) KMT2AAURKATP53MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 CA12 1467/4885CA9 436/4885KMT2A 60/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 CA12 1467/4885CA9 436/4885KMT2A 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.